Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel mutation
Permanent neonatal diabetes mellitus refers to diabetes that occurs before the age of 6 months and persists through life. It is a rare disorder affecting one in 0.2-0.5 million live births. Mutations in the gene KCNJ11, encoding the subunit Kir6.2, and ABCC8, encoding SUR1 of the ATP-sensitive potas...
Saved in:
Main Authors: | Sung Yeon Ahn (Author), Gu-Hwan Kim (Author), Han-Wook Yoo (Author) |
---|---|
Format: | Book |
Published: |
Korean Pediatric Society,
2015-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neonatal Diabetes Mellitus Due to KCNJ11 (KIR6.2) Mutation Successfully Treated with Sulfonylurea
by: Sehun Jang, et al.
Published: (2021) -
Consensus recommendations on sulfonylurea & sulfonylurea combinations in the management of Type 2 diabetes mellitus - international task force
by: Sanjay Kalra, et al.
Published: (2019) -
Permanent neonatal diabetes mellitus in an Indian infant due to a novel mutation in the glucokinase gene
by: Kagithapu Surender, et al.
Published: (2021) -
Transient neonatal diabetes mellitus with macroglossia diagnosed by methylation specific PCR (MS-PCR)
by: Hye Young Jin, et al.
Published: (2010) -
Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in
by: Jong Seo Yoon, et al.
Published: (2018)